Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
265
NCT02319941
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
Phase: Phase 2
Role: Collaborator
Start: May 20, 2015
Completion: Mar 10, 2017
NCT06716255
Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome
Phase: N/A
Role: Lead Sponsor
Start: Feb 29, 2024
Completion: Sep 24, 2024